The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.

Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.

Zhitong FinanceMar 18 03:00 ET

Indivior PLC Publishes 2024 Annual Report

TipRanksMar 17 09:23 ET

New York Manufacturing Hits Low, Inflation Fears Rise

InvestingMar 17 08:50 ET

Madison Avenue Partners Increases Stake in Indivior PLC

TipRanksMar 14 06:07 ET

Indivior PLC Grants Long-Term Incentive Awards to Key Executives

TipRanksMar 10 13:49 ET

Piper Sandler Maintains Overweight on Indivior, Lowers Price Target to $13

BenzingaMar 6 09:14 ET · Ratings

Indivior Analyst Ratings

BenzingaMar 6 09:12 ET · Ratings

Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $13

Moomoo NewsMar 6 07:31 ET · Ratings

Indivior Price Target Lowered to $13 From $16 at Piper Sandler

TipRanksMar 6 06:52 ET

Indivior Executive and Associate Increase Shareholding

TipRanksMar 5 09:07 ET

Indivior to Cut Board Size at May Shareholders' Meeting

MT NewswiresMar 4 03:57 ET

Indivior Announces Strategic Board Restructuring

TipRanksMar 4 02:08 ET

Indivior | 10-K: FY2024 Annual Report

SECMar 3 16:36 ET · Announcements

Is Indivior PLC (INDV) the Best Small Cap Pharma Stock to Buy Now?

Yahoo FinanceMar 2 18:36 ET

Trending Stocks Today | Longeveron Surges 25% Post-Market

Moomoo NewsFeb 28 17:35 ET

Indivior Director Acquires 15,000 Shares, Signaling Confidence

TipRanksFeb 28 04:48 ET

Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating

Moomoo NewsFeb 27 09:33 ET · Ratings

Craig-Hallum Keeps Their Buy Rating on Indivior (INDV)

TipRanksFeb 27 09:09 ET · Ratings

Indivior CEO Mark Crossley to Step Down, Joe Ciaffoni to Succeed

TipRanksFeb 27 05:30 ET

Indivior CEO to Step Down; Successor Named

MT NewswiresFeb 27 03:12 ET